Join the BioNap Email List!

Friday, September 18, 2015

A Quick Look At BioLineRx

BioLineRx is a publicly-traded (NASDAQ:BLRX), clinical-stage biopharmaceutical company based in Israel, dedicated to identifying, in-licensing and developing promising therapeutic candidates. The company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then seeks to partner with pharmaceutical companies for advanced clinical development and/or commercialization.

Please read the full article on Seeking-Alpha: LINK

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.